234 related articles for article (PubMed ID: 11060357)
1. Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.
Sviridov D; Pyle LE; Jauhiainen M; Ehnholm C; Fidge NH
J Lipid Res; 2000 Nov; 41(11):1872-82. PubMed ID: 11060357
[TBL] [Abstract][Full Text] [Related]
2. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
Huang W; Matsunaga A; Li W; Han H; Hoang A; Kugi M; Koga T; Sviridov D; Fidge N; Sasaki J
Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210
[TBL] [Abstract][Full Text] [Related]
3. High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression.
Sorci-Thomas MG; Parks JS; Kearns MW; Pate GN; Zhang C; Thomas MJ
J Lipid Res; 1996 Mar; 37(3):673-83. PubMed ID: 8728328
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
Huang W; Sasaki J; Matsunaga A; Han H; Li W; Koga T; Kugi M; Ando S; Arakawa K
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):210-6. PubMed ID: 10634820
[TBL] [Abstract][Full Text] [Related]
5. High yield overexpression and characterization of human recombinant proapolipoprotein A-I.
McGuire KA; Davidson WS; Jonas A
J Lipid Res; 1996 Jul; 37(7):1519-28. PubMed ID: 8827524
[TBL] [Abstract][Full Text] [Related]
6. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo.
Scott BR; McManus DC; Franklin V; McKenzie AG; Neville T; Sparks DL; Marcel YL
J Biol Chem; 2001 Dec; 276(52):48716-24. PubMed ID: 11602583
[TBL] [Abstract][Full Text] [Related]
8. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
[TBL] [Abstract][Full Text] [Related]
10. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
12. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
Cho KH; Durbin DM; Jonas A
J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
[TBL] [Abstract][Full Text] [Related]
13. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.
Francone OL; Royer L; Haghpassand M
J Lipid Res; 1996 Jun; 37(6):1268-77. PubMed ID: 8808761
[TBL] [Abstract][Full Text] [Related]
14. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
[TBL] [Abstract][Full Text] [Related]
15. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants.
Sviridov D; Pyle LE; Fidge N
J Biol Chem; 1996 Dec; 271(52):33277-83. PubMed ID: 8969186
[TBL] [Abstract][Full Text] [Related]
16. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R
J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I: structure-function relationships.
Frank PG; Marcel YL
J Lipid Res; 2000 Jun; 41(6):853-72. PubMed ID: 10828078
[TBL] [Abstract][Full Text] [Related]
19. The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle.
Durbin DM; Jonas A
J Biol Chem; 1997 Dec; 272(50):31333-9. PubMed ID: 9395462
[TBL] [Abstract][Full Text] [Related]
20. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]